| CYSB2500084 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2025-04-16 | | Taizhou Maibotaike Pharmaceutical Co Ltd;Jinyu Bowo Runze Biotechnology Co Ltd | | | view |
| CYSB2500015 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-01-11 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2500014 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-01-11 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2500013 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-01-11 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2400325 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-12-14 | | Livzon Mabpharm INC | | | view |
| CYSB2400221 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-08-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2400220 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-08-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2400110 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2400108 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2400109 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-09 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2300064 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche Registration GmbH | | | view |
| JYSB2300050 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300052 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300051 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-14 | | Roche Pharma (Schweiz) AG;Chugai Pharma Manufacturing Co Ltd | | | view |
| JYSB2300041 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products | Supplementary Application | 2023-03-04 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche Registration GmbH | | | view |
| CYSB2300049 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-22 | | Livzon Mabpharm INC | | | view |
| CYSB2300048 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | Supplementary Application | 2023-02-22 | | Livzon Mabpharm INC | | | view |
| CXSS2300005 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-07 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSS2300001 | 托珠单抗注射液 | tocilizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-07 | | Taizhou Maibotaike Pharmaceutical Co Ltd;Jinyu Bowo Runze Biotechnology Co Ltd | | | view |
| JXSS2200037 | 托珠单抗注射液（皮下注射） | tocilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-11-21 | | Vetter Pharma-Fertigung Gmbh & Co KG;Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
